Advancing the Real-World Evidence for Medical Devices through Coordinated Registry Networks
Open Access
- 11 November 2022
- journal article
- research article
- Published by BMJ in BMJ Surgery, Interventions, & Health Technologies
- Vol. 4 (Suppl 1) , e000123
Abstract
Objectives Generating and using real-world evidence (RWE) is a pragmatic solution for evaluating health technologies. RWE is recognized by regulators, health technology assessors, clinicians, and manufacturers as a valid source of information to support their decision-making. Well-designed registries can provide RWE and become more powerful when linked with electronic health records and administrative databases in coordinated registry networks (CRNs). Our objective was to create a framework of maturity of CRNs and registries, so guiding their development and the prioritization of funding. Design, setting, and participants We invited 52 stakeholders from diverse backgrounds including patient advocacy groups, academic, clinical, industry and regulatory experts to participate on a Delphi survey. Of those invited, 42 participated in the survey to provide feedback on the maturity framework for CRNs and registries. An expert panel reviewed the responses to refine the framework until the target consensus of 80% was reached. Two rounds of the Delphi were distributed via Qualtrics online platform from July to August 2020 and from October to November 2020. Main outcome measures Consensus on the maturity framework for CRNs and registries consisted of seven domains (unique device identification, efficient data collection, data quality, product life cycle approach, governance and sustainability, quality improvement, and patient-reported outcomes), each presented with five levels of maturity. Results Of 52 invited experts, 41 (79.9%) responded to round 1; all 41 responded to round 2; and consensus was reached for most domains. The expert panel resolved the disagreements and final consensus estimates ranged from 80.5% to 92.7% for seven domains. Conclusions We have developed a robust framework to assess the maturity of any CRN (or registry) to provide reliable RWE. This framework will promote harmonization of approaches to RWE generation across different disciplines and health systems. The domains and their levels may evolve over time as new solutions become available.Keywords
Funding Information
- U.S. Food and Drug Administration (U01FD006936)
This publication has 30 references indexed in Scilit:
- Variations in Abdominal Aortic Aneurysm Care: A Report From the International Consortium of Vascular RegistriesCirculation, 2016
- Use and risks of surgical mesh for pelvic organ prolapse surgery in women in New York state: population based cohort studyBMJ, 2015
- Transcatheter Aortic Valve Implantation in the United KingdomCirculation, 2015
- Distributed Analysis of Hip Implants Using Six National and Regional Registries: Comparing Metal-on-Metal with Metal-on-Highly Cross-Linked Polyethylene Bearings in Cementless Total Hip Arthroplasty in Young PatientsJournal of Bone and Joint Surgery, 2014
- Breast Implant–Associated Anaplastic Large-Cell Lymphoma: Long-Term Follow-Up of 60 PatientsJournal of Clinical Oncology, 2014
- The Randomized Registry Trial — The Next Disruptive Technology in Clinical Research?New England Journal of Medicine, 2013
- The STS-ACC Transcatheter Valve Therapy National RegistryJACC, 2013
- The 510(k) Ancestry of a Metal-on-Metal Hip ImplantNew England Journal of Medicine, 2013
- The Society for Vascular Surgery Vascular Quality InitiativeJournal of Vascular Surgery, 2012
- Comparative assessment of implantable hip devices with different bearing surfaces: systematic appraisal of evidenceBMJ, 2011